To view the PDF file, sign up for a MySharenet subscription.

ASSURA PLC - Board Change

Release Date: 19/08/2025 08:00
Code(s): AHR     PDF:  
Wrap Text
Board Change

Assura plc
(Incorporated in England and Wales)
(Company Number: 09349441)
LEI number: 21380026T19N2Y52XF72
LSE Share Code: AGR
JSE Share Code: AHR
ISIN Code: GB00BVGBWW93
("Assura")



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY
OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD
CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH
JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE


Board change


Assura announces that Ed Smith, CBE, Non-Executive Chair of Assura, has informed the company
that he is resigning from his office as a director and Non-Executive Chair with immediate effect.

Ed Smith joined the Assura Board in 2017 and was appointed Chair in 2018. During his time as Chair
he has provided critical oversight of Assura's strategy and governance, building on his extensive
health service, public sector and business experience. Through his strong leadership of the board,
Assura has been successful in delivering for its shareholders and its wider stakeholder group,
including the National Health Service.

The board of directors of Assura notes the offer for Assura by Primary Health Properties PLC ("PHP"),
which was declared wholly unconditional on 12 August 2025, and which currently remains open for
acceptance until further notice. If PHP acquires Assura shares carrying 75 per cent. or more of the
voting rights of Assura, PHP intends to procure the delisting and cancellation of trading of Assura's
shares from the London Stock Exchange and the Johannesburg Stock Exchange.

In this context, the board of directors of Assura has appointed the Senior Non-Executive Director,
Jonathan Davies, as Chair.

Jonathan Murphy, Chief Executive Officer of Assura, commented:

"We sincerely thank Ed for his huge contribution to the success of Assura over the past seven years.
His guidance and support to me and the wider team has been invaluable. I know that I can speak for
everyone in Assura in wishing him all the best for the future."

Jonathan Davies, Non-Executive Chair of Assura, commented:

"On behalf of the Board, I would like to thank Ed for his fantastic leadership and stewardship of the
business during his term as Chair. Ed has played a vital role in driving Assura's performance and
developing its long-term strategy, whilst never losing focus on its strong social purpose and the need
to support the NHS. Both the Board and the wider business have been very fortunate to benefit from
his deep knowledge and experience of the health sector. It has been a great privilege to work
alongside Ed during all of his term as Chair and I now look forward to leading the Board during the
CMA process."

Enquiries

Assura plc                                                                          0161 515 2043
Jonathan Murphy
Jayne Cottam

FGS Global (PR Adviser to Assura)                                                   020 7251 3801
Gordon Simpson
Anjali Unnikrishnan
Grace Whelan

Inside Information

This Announcement contains inside information as defined in the UK version of the Market Abuse
Regulation (EU) No 596/2014, which is part of UK domestic law by virtue of the European Union
(Withdrawal) Act 2018. Upon the publication of this Announcement via a Regulatory Information
Service, such inside information will be considered to be in the public domain.

The person responsible for arranging the release of this Announcement on behalf of Assura is Orla
Ball, Company Secretary and General Counsel.


19 August 2025

JSE Sponsor

Nedbank Corporate and Investment Banking, a division of Nedbank Limited

Date: 19-08-2025 08:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.